Targeted Drug for Advanced Pancreatic Cancer Sparks Early Enthusiasm

By News Health
2 months Ago

(MedPage Today) — SAN FRANCISCO — Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease control with a novel KRAS G12D inhibitor, a small preliminary study showed.
The early results showed that…

Source link : https://www.medpagetoday.com/meetingcoverage/mgics/119372

Author :

Publish date : 2026-01-10 14:01:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

'I have four months left to preserve my fertility'

Inside the world of looksmaxxing

Quiz Time: Why Did RFK Jr. Have Surgery?

Potential Benefits and Harms of Colon Cancer Screening; Sleep in Adolescents

How to Contain Healthcare Costs

Doja Opens Up About Her Liposuction, Says She May Have Lipedema